NM_000372.5(TYR):c.113C>T (p.Pro38Leu) AND not provided

Germline classification:: Uncertain significance (2 submissions)
Last evaluated:: Mar 1, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001883865.10

Allele description [Variation Report for NM_000372.5(TYR):c.113C>T (p.Pro38Leu)]

NM_000372.5(TYR):c.113C>T (p.Pro38Leu)

Gene:

TYR:tyrosinase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

11q14.3

Genomic location:

Preferred name:

NM_000372.5(TYR):c.113C>T (p.Pro38Leu)

HGVS:

NC_000011.10:g.89178066C>T
NG_008748.1:g.5195C>T
NM_000372.5:c.113C>TMANE SELECT
NP_000363.1:p.Pro38Leu
NC_000011.9:g.88911234C>T

Protein change:

P38L

Links:

dbSNP: rs759624945

NCBI 1000 Genomes Browser:

rs759624945

Molecular consequence:

NM_000372.5:c.113C>T - missense variant - [Sequence Ontology: SO:0001583]

Observations:

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

MAPK/MAK/MRK overlapping kinase isoform X10 [Homo sapiens]
MAPK/MAK/MRK overlapping kinase isoform X10 [Homo sapiens]
gi|2462541207|ref|XP_054232504.1|

Protein
PREDICTED: Homo sapiens MOK protein kinase (MOK), transcript variant X14, mRNA
PREDICTED: Homo sapiens MOK protein kinase (MOK), transcript variant X14, mRNA
gi|2462541208|ref|XM_054376530.1|

Nucleotide
PREDICTED: Homo sapiens MOK protein kinase (MOK), transcript variant X7, mRNA
PREDICTED: Homo sapiens MOK protein kinase (MOK), transcript variant X7, mRNA
gi|2462541194|ref|XM_054376523.1|

Nucleotide
PREDICTED: Homo sapiens MOK protein kinase (MOK), transcript variant X3, misc_RN...
PREDICTED: Homo sapiens MOK protein kinase (MOK), transcript variant X3, misc_RNA
gi|2217298189|ref|XR_007064040.1|

Nucleotide
Homo sapiens MOK protein kinase (MOK), transcript variant 1, mRNA
Homo sapiens MOK protein kinase (MOK), transcript variant 1, mRNA
gi|1519244828|ref|NM_014226.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002138273	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jun 20, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV004811840	CeGaT Center for Human Genetics Tuebingen	criteria provided, single submitter (CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)	Uncertain significance (Mar 1, 2024)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002138273

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jun 20, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004811840

CeGaT Center for Human Genetics Tuebingen

criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)

Uncertain significance
(Mar 1, 2024)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	1	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002138273.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 38 of the TYR protein (p.Pro38Leu). This variant is present in population databases (rs759624945, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TYR-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TYR protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From CeGaT Center for Human Genetics Tuebingen, SCV004811840.7

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

TYR: PM1, PM2, PP4

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Oct 20, 2024

ClinVar

Relating variation to medicine